Recent studies examine Namilumab, a engineered antibody directed CSF2 (Colony Stimulating Factor 2), also known as GM-CSF. This innovative therapeutic strategy is showing potential in treating conditions https://adrianaccts064568.wikipublicity.com/8701383/namilumab_a_deep_dive_into_the_csf2_antibody_medication